256 related articles for article (PubMed ID: 2483429)
1. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
3. Ramipril: a review of the new ACE inhibitor.
Mills TP
J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of ramipril.
Ball SG; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
[TBL] [Abstract][Full Text] [Related]
5. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
[TBL] [Abstract][Full Text] [Related]
6. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
Böhm RO; van Baak MA; Rahn KH
Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
[TBL] [Abstract][Full Text] [Related]
7. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
Clauser E
Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
10. [Long-term blood pressure measurement for evaluating the first dose response of captopril and ramipril in patients with a stimulated renin system].
Lüders S; Schrader J; Schoel G; Ruschitzka F; Scheler F
Z Kardiol; 1992; 81 Suppl 2():41-4. PubMed ID: 1387500
[TBL] [Abstract][Full Text] [Related]
11. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
12. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
Todd PA; Benfield P
Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K
Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405
[TBL] [Abstract][Full Text] [Related]
15. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril.
Predel HG; Düsing R; Bäcker A; Kipnowski J; Kramer HJ
Am J Cardiol; 1987 Apr; 59(10):143D-148D. PubMed ID: 3034023
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105
[TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
de Graeff PA; Kingma JH; Dunselman PH; Wesseling H; Lie KI
Am J Cardiol; 1987 Apr; 59(10):164D-170D. PubMed ID: 3034026
[TBL] [Abstract][Full Text] [Related]
20. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Becker RH; Baldes L; Treudler M
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
